Skip to content

Nuvation Bio NUVB Accounts Payable

Accounts Payable at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$4.23B+5.8%
Pfizer logo
PfizerPFE
$4.51B-14.0%
Nuvalent, Inc. logo
Nuvalent, Inc.NUVL
$22.14M-15.4%
Immunome logo
ImmunomeIMNM
$5.53M-39.4%
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
$8.73M+100.0%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$39M+77.3%

Other financials

Income statement

See full
Revenue$83.2M+2,599%
Gross profit$9.8M+1,340%
Operating income$3.9M+107%
Net income$5.4M+110%
EPS (diluted)$0.01+106%

Balance sheet

See full
Cash & equivalents$125.4M+161%
Total debt$57.2M+401%
Total equity$319.6M-23.8%
Total assets$610.2M+23.9%

Cash flow

See full
Operating cash flow$5.1M+112%
CapEx$48.0K-33.3%
Free cash flow$5.0M+112%

Valuation

See full
Market cap$2.1B+150%
Enterprise value$2.03B+154%
P/S14.7×-62.0×

Profitability

See full
Gross margin54.3%+39.5pp
Operating margin-105%-52.0pp
Net margin-102.1%-50.6pp
FCF margin-93.5%-45.2pp

Returns & leverage

See full
Return on equity-39.5%-15.8pp
Debt / equity0.2×+0.2×
Current ratio7.4×-1.6×

Where this comes from

Reported directly by Nuvation Bio in its filing.

Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.

The official record: Nuvation Bio’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvation Bio's accounts payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nuvation Bio's accounts payable?
Nuvation Bio (NUVB) reported accounts payable of $22.44M in Q1 2026.
How has Nuvation Bio's accounts payable changed year-over-year?
Nuvation Bio's accounts payable increased by 112.9% year-over-year, from $10.54M to $22.44M.
What is the long-term trend for Nuvation Bio's accounts payable?
Over 4 years (2021 to 2025), Nuvation Bio's accounts payable has grown at a 31.1% compound annual growth rate (CAGR), from $19.59M to $57.8M.
What does accounts payable mean?
Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.